e-ISSN: Pending
Failed Experiment ReportOpen accessMedicine

Efficacy assessment of a novel endolysin PlyAZ3aT for the treatment of ceftriaxone-resistant pneumococcal meningitis in an infant rat model.

Luca G Valente; Ngoc Dung Le; Melissa Pitton; Gabriele Chiffi; Denis Grandgirard; Stephan M Jakob; David R Cameron; Grégory Resch · 2022 · PLoS ONE

WASTE classifies this as Failed Experiment Report · AI classification, approximate

An experimental approach did not work as intended — learn what to avoid before investing the same effort.

Abstract

Background Treatment failure in pneumococcal meningitis due to antibiotic resistance is an increasing clinical challenge and alternatives to antibiotics warrant investigation. Phage-derived endolysins efficiently kill gram-positive bacteria including multi-drug resistant strains, making them attractive therapeutic candidates. The current study assessed the therapeutic potential of the novel endolysin PlyAZ3aT in an infant rat model of ceftriaxone-resistant pneumococcal meningitis. Methods Efficacy of PlyAZ3aT was assessed in a randomized, blinded and controlled experimental study in infant Wis

Abstract by Luca G Valente; Ngoc Dung Le; Melissa Pitton; Gabriele Chiffi; Denis Grandgirard; Stephan M Jakob; David R Cameron; Grégory Resch, PLoS ONE (2022) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1371/journal.pone.0266928